Wuhan Net Receivables vs Other Current Liab Analysis

300871 Stock   12.67  0.34  2.76%   
Wuhan Hvsen financial indicator trend analysis is more than just analyzing Wuhan Hvsen Biotechnology current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Wuhan Hvsen Biotechnology is a good investment. Please check the relationship between Wuhan Hvsen Net Receivables and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wuhan Hvsen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Net Receivables vs Other Current Liab

Net Receivables vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Wuhan Hvsen Biotechnology Net Receivables account and Other Current Liab. At this time, the significance of the direction appears to have weak relationship.
The correlation between Wuhan Hvsen's Net Receivables and Other Current Liab is 0.38. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Wuhan Hvsen Biotechnology, assuming nothing else is changed. The correlation between historical values of Wuhan Hvsen's Net Receivables and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Wuhan Hvsen Biotechnology are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Receivables i.e., Wuhan Hvsen's Net Receivables and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.38
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Receivables

Other Current Liab

Most indicators from Wuhan Hvsen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Wuhan Hvsen Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Wuhan Hvsen Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about (4.1 M). In addition to that, Selling General Administrative is expected to decline to about 52.6 M
 2023 2024 (projected)
Minority Interest17.0K14.4K
Income Tax Expense4.6M4.4M

Wuhan Hvsen fundamental ratios Correlations

0.320.040.240.50.320.320.380.360.440.330.060.490.30.040.380.440.570.280.430.440.360.140.30.40.73
0.320.910.890.891.00.680.980.94-0.020.57-0.340.90.970.90.970.920.651.00.220.910.890.90.990.960.43
0.040.910.940.820.90.640.890.86-0.050.53-0.310.810.860.990.90.850.590.920.150.820.880.950.90.890.29
0.240.890.940.920.890.780.930.930.150.61-0.340.940.890.930.950.960.770.90.40.940.990.910.890.950.58
0.50.890.820.920.90.830.960.940.230.78-0.340.970.880.80.950.960.820.880.530.940.950.810.870.950.7
0.321.00.90.890.90.670.980.95-0.040.56-0.370.90.970.90.970.920.661.00.220.910.890.90.990.960.44
0.320.680.640.780.830.670.780.690.470.7-0.40.80.620.570.730.820.530.640.840.840.840.490.590.740.74
0.380.980.890.930.960.980.780.970.080.68-0.380.960.950.880.990.970.730.970.380.950.950.880.960.980.56
0.360.940.860.930.940.950.690.970.020.65-0.360.970.980.870.980.960.840.950.30.940.930.910.960.990.57
0.44-0.02-0.050.150.23-0.040.470.080.020.410.510.2-0.05-0.090.060.20.11-0.070.660.250.23-0.16-0.10.070.55
0.330.570.530.610.780.560.70.680.650.410.010.650.540.490.60.630.530.540.520.60.620.480.520.60.47
0.06-0.34-0.31-0.34-0.34-0.37-0.4-0.38-0.360.510.01-0.36-0.35-0.28-0.37-0.38-0.29-0.35-0.28-0.36-0.36-0.28-0.34-0.37-0.26
0.490.90.810.940.970.90.80.960.970.20.65-0.360.930.810.970.990.870.90.490.980.970.830.90.980.75
0.30.970.860.890.880.970.620.950.98-0.050.54-0.350.930.880.980.930.750.980.190.920.890.910.980.970.48
0.040.90.990.930.80.90.570.880.87-0.090.49-0.280.810.880.90.840.610.920.070.810.870.980.920.890.26
0.380.970.90.950.950.970.730.990.980.060.6-0.370.970.980.90.980.790.980.330.970.960.910.971.00.59
0.440.920.850.960.960.920.820.970.960.20.63-0.380.990.930.840.980.830.920.490.990.990.850.910.990.72
0.570.650.590.770.820.660.530.730.840.110.53-0.290.870.750.610.790.830.670.360.780.790.730.710.810.75
0.281.00.920.90.881.00.640.970.95-0.070.54-0.350.90.980.920.980.920.670.160.90.890.921.00.970.41
0.430.220.150.40.530.220.840.380.30.660.52-0.280.490.190.070.330.490.360.160.530.510.010.120.350.82
0.440.910.820.940.940.910.840.950.940.250.6-0.360.980.920.810.970.990.780.90.530.980.80.890.970.74
0.360.890.880.990.950.890.840.950.930.230.62-0.360.970.890.870.960.990.790.890.510.980.850.880.960.69
0.140.90.950.910.810.90.490.880.91-0.160.48-0.280.830.910.980.910.850.730.920.010.80.850.940.910.3
0.30.990.90.890.870.990.590.960.96-0.10.52-0.340.90.980.920.970.910.711.00.120.890.880.940.960.4
0.40.960.890.950.950.960.740.980.990.070.6-0.370.980.970.891.00.990.810.970.350.970.960.910.960.61
0.730.430.290.580.70.440.740.560.570.550.47-0.260.750.480.260.590.720.750.410.820.740.690.30.40.61
Click cells to compare fundamentals

Wuhan Hvsen Account Relationship Matchups

Wuhan Hvsen fundamental ratios Accounts

201920202021202220232024 (projected)
Other Current Liab22.2M45.0M57.9M61.5M3.8M3.7M
Total Current Liabilities203.8M338.7M503.3M804.9M781.1M410.7M
Other Liab24.3M28.0M45.0M72.4M83.3M87.4M
Net Tangible Assets280.1M1.3B1.5B1.4B1.6B1.7B
Retained Earnings191.6M341.8M429.3M427.1M341.9M271.4M
Accounts Payable121.1M194.4M311.3M489.7M472.5M240.9M
Other Assets26.0M67.0M25.9M32.7M37.6M26.7M
Net Receivables107.0M201.7M259.5M338.0M318.5M190.8M
Inventory72.4M127.3M231.6M199.0M228.7M144.0M
Other Current Assets8.7M25.0M9.4M8.6M5.3M9.1M
Total Current Assets292.5M1.2B1.6B1.4B1.3B863.0M
Property Plant Equipment233.3M412.3M1.0B1.5B1.7B1.8B
Total Assets650.1M1.8B2.7B3.0B3.0B1.9B
Total Stockholder Equity378.3M1.4B1.6B1.5B1.5B1.1B
Cash104.5M345.3M1.1B424.0M293.6M375.3M
Non Current Assets Total357.5M575.1M1.1B1.6B1.7B908.3M
Non Currrent Assets Other15.5M56.7M15.5M7.5M3.6M3.4M
Non Current Liabilities Total68.0M34.4M619.5M642.8M685.1M719.4M
Total Liab271.8M373.1M1.1B1.4B1.5B777.0M
Net Invested Capital441.0M1.4B2.3B2.3B2.4B1.5B
Net Working Capital88.8M838.5M1.1B546.5M484.9M510.8M
Intangible Assets98.2M95.8M110.1M106.9M104.2M101.2M
Short Long Term Debt29M63M100M220.1M240.3M124.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Wuhan Stock

Balance Sheet is a snapshot of the financial position of Wuhan Hvsen Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Wuhan Hvsen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Wuhan Hvsen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Wuhan currently owns. An asset can also be divided into two categories, current and non-current.